FDA greenlights Exact Science’s newest home colorectal cancer test
The US Food and Drug Administration (FDA) has approved the second version of Exact Science’s at-home colorectal cancer (CRC) test,…
All articles by Phalguni Deswal
Phalguni Deswal
@Phalguni_GD
Phalguni Deswal is reporter in the healthcare and pharmaceutical sector. With a background in medicine, Phalguni has experience working in the Indian healthcare sector. Phalguni is interested in metabolic drug therapies, digital health technologies, and drug development.
-
-
FDA greenlights OrthAlign’s handheld Lantern Hip navigation system
OrthAlign has expanded its portfolio of Lantern handheld navigation systems by securing a 510(k) clearance from the US Food and…
-
Qnovia set to trial smoking cessation inhaler in the US
Qnovia has received clearance from the US Food and Drug Administration (FDA) to start a clinical trial for its RespiRX…
-
Perimeter completes enrolment for AI-assisted breast imaging trial
Perimeter Medical Imaging AI has completed enrolment for the pivotal trial of its AI-assisted imaging technology, the Perimeter B-Series OCT…
-
Qiagen secures EU IVDR certification for QIAstat-Dx systems and panels
Qiagen has received the CE mark for its QIAstat-Dx syndromic testing systems and associated assays under the European Union (EU)’s…
-
Mediwhale secures $12m for AI-powered retina scan
South Korea-based Mediwhale has raised $12m in Series A2 financing round to advance its AI-powered retina scan technology, Reti-CVD, to…
-
Wesper sleep platform reduces nerve stimulation titration time by 45%
New York-based home sleep diagnostics company Wesper has released findings from a case study on hypoglossal nerve stimulation (HGNS) for…
-
Bridge to Life bolsters efficacy data for HOPE perfusion device in liver transplant
Bridge to Life has unveiled data from three Italian trials for its mechanical perfusion device, HOPE [hypothermic oxygenated perfusion], showing…
-
Aditxt and Evofem partner to launch endometriosis diagnostic in 2025
Aditxt has signed a market development collaboration agreement with Evofem Biosciences to commercialise the former’s blood-based diagnostic test for endometriosis.…
-
ClaroNav expands FDA label for Navident dental imaging system
The US Food and Drug Administration (FDA) has approved a label expansion for ClaroNav’s dental navigation system, Navident EVO, to…